United States Omeprazole Market Report 2016

Publisher Name :
Date: 13-Oct-2016
No. of pages: 118
Inquire Before Buying

Notes:

Sales, means the sales volume of Omeprazole

Revenue, means the sales value of Omeprazole

This report studies sales (consumption) of Omeprazole in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Apotex

- Dr reddys laboratories

- Impax laboratories

- Kremers urban development

- Lek pharmaceuticals

- Mylan pharmaceuticals

- Sandoz

- Watson laboratories

- Astrazeneca

- Dexcel pharma technologies

- Santarus

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Capsule

- Sustained Release Tablet

- Others

Split by applications, this report focuses on sales, market share and growth rate of Omeprazole in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Omeprazole Market Report 2016

Table of Contents
United States Omeprazole Market Report 2016
1 Omeprazole Overview
1.1 Product Overview and Scope of Omeprazole
1.2 Classification of Omeprazole
1.2.1 Capsule
1.2.2 Sustained Release Tablet
1.2.3 Others
1.3 Application of Omeprazole
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Omeprazole (2011-2021)
1.4.1 United States Omeprazole Sales and Growth Rate (2011-2021)
1.4.2 United States Omeprazole Revenue and Growth Rate (2011-2021)
2 United States Omeprazole Competition by Manufacturers
2.1 United States Omeprazole Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Omeprazole Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Omeprazole Average Price by Manufactures (2015 and 2016)
2.4 Omeprazole Market Competitive Situation and Trends
2.4.1 Omeprazole Market Concentration Rate
2.4.2 Omeprazole Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Omeprazole Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Omeprazole Sales and Market Share by Type (2011-2016)
3.2 United States Omeprazole Revenue and Market Share by Type (2011-2016)
3.3 United States Omeprazole Price by Type (2011-2016)
3.4 United States Omeprazole Sales Growth Rate by Type (2011-2016)
4 United States Omeprazole Sales (Volume) by Application (2011-2016)
4.1 United States Omeprazole Sales and Market Share by Application (2011-2016)
4.2 United States Omeprazole Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Omeprazole Manufacturers Profiles/Analysis
5.1 Apotex
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Omeprazole Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Apotex Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Dr reddys laboratories
5.2.2 Omeprazole Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Dr reddys laboratories Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Impax laboratories
5.3.2 Omeprazole Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Impax laboratories Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Kremers urban development
5.4.2 Omeprazole Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Kremers urban development Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Lek pharmaceuticals
5.5.2 Omeprazole Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Lek pharmaceuticals Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Mylan pharmaceuticals
5.6.2 Omeprazole Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Mylan pharmaceuticals Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Sandoz
5.7.2 Omeprazole Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 SandozOmeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Watson laboratories
5.8.2 Omeprazole Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Watson laboratories Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Astrazeneca
5.9.2 Omeprazole Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Astrazeneca Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Dexcel pharma technologies
5.10.2 Omeprazole Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Dexcel pharma technologiesOmeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Santarus
6 Omeprazole Manufacturing Cost Analysis
6.1 Omeprazole Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Omeprazole
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Omeprazole Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Omeprazole Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Omeprazole Market Forecast (2016-2021)
10.1 United States Omeprazole Sales, Revenue Forecast (2016-2021)
10.2 United States Omeprazole Sales Forecast by Type (2016-2021)
10.3 United States Omeprazole Sales Forecast by Application (2016-2021)
10.4 Omeprazole Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Omeprazole
Table Classification of Omeprazole
Figure United States Sales Market Share of Omeprazole by Type in 2015
Figure Capsule Picture
Figure Sustained Release Tablet Picture
Figure Others Picture
Table Application of Omeprazole
Figure United States Sales Market Share of Omeprazole by Application in 2015
Figure United States Omeprazole Sales and Growth Rate (2011-2021)
Figure United States Omeprazole Revenue and Growth Rate (2011-2021)
Table United States Omeprazole Sales of Key Manufacturers (2015 and 2016)
Table United States Omeprazole Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Omeprazole Sales Share by Manufacturers
Figure 2016 Omeprazole Sales Share by Manufacturers
Table United States Omeprazole Revenue by Manufacturers (2015 and 2016)
Table United States Omeprazole Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Omeprazole Revenue Share by Manufacturers
Table 2016 United States Omeprazole Revenue Share by Manufacturers
Table United States Market Omeprazole Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Omeprazole Average Price of Key Manufacturers in 2015
Figure Omeprazole Market Share of Top 3 Manufacturers
Figure Omeprazole Market Share of Top 5 Manufacturers
Table United States Omeprazole Sales by Type (2011-2016)
Table United States Omeprazole Sales Share by Type (2011-2016)
Figure United States Omeprazole Sales Market Share by Type in 2015
Table United States Omeprazole Revenue and Market Share by Type (2011-2016)
Table United States Omeprazole Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Omeprazole by Type (2011-2016)
Table United States Omeprazole Price by Type (2011-2016)
Figure United States Omeprazole Sales Growth Rate by Type (2011-2016)
Table United States Omeprazole Sales by Application (2011-2016)
Table United States Omeprazole Sales Market Share by Application (2011-2016)
Figure United States Omeprazole Sales Market Share by Application in 2015
Table United States Omeprazole Sales Growth Rate by Application (2011-2016)
Figure United States Omeprazole Sales Growth Rate by Application (2011-2016)
Table Apotex Basic Information List
Table Apotex Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Apotex Omeprazole Sales Market Share (2011-2016)
Table Dr reddys laboratories Basic Information List
Table Dr reddys laboratories Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dr reddys laboratories Omeprazole Sales Market Share (2011-2016)
Table Impax laboratories Basic Information List
Table Impax laboratories Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
Table Impax laboratories Omeprazole Sales Market Share (2011-2016)
Table Kremers urban development Basic Information List
Table Kremers urban development Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kremers urban development Omeprazole Sales Market Share (2011-2016)
Table Lek pharmaceuticals Basic Information List
Table Lek pharmaceuticals Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lek pharmaceuticals Omeprazole Sales Market Share (2011-2016)
Table Mylan pharmaceuticals Basic Information List
Table Mylan pharmaceuticals Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan pharmaceuticals Omeprazole Sales Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz Omeprazole Sales Market Share (2011-2016)
Table Watson laboratories Basic Information List
Table Watson laboratories Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
Table Watson laboratories Omeprazole Sales Market Share (2011-2016)
Table Astrazeneca Basic Information List
Table Astrazeneca Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astrazeneca Omeprazole Sales Market Share (2011-2016)
Table Dexcel pharma technologies Basic Information List
Table Dexcel pharma technologies Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dexcel pharma technologies Omeprazole Sales Market Share (2011-2016)
Table Santarus Basic Information List
Table Santarus Omeprazole Sales, Revenue, Price and Gross Margin (2011-2016)
Table Santarus Omeprazole Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Omeprazole
Figure Manufacturing Process Analysis of Omeprazole
Figure Omeprazole Industrial Chain Analysis
Table Raw Materials Sources of Omeprazole Major Manufacturers in 2015
Table Major Buyers of Omeprazole
Table Distributors/Traders List
Figure United States Omeprazole Production and Growth Rate Forecast (2016-2021)
Figure United States Omeprazole Revenue and Growth Rate Forecast (2016-2021)
Table United States Omeprazole Production Forecast by Type (2016-2021)
Table United States Omeprazole Consumption Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • EMEA (Europe, Middle East and Africa) Non-Gelatin Empty Capsules Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 118
    In this report, the EMEA Non-Gelatin Empty Capsules market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Non-Gelatin Empty Capsules for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy a......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 127
    In this report, the global Foot and Mouth Disease (FMD) Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Foot and Mouth Disease (FMD) Vaccines in these regions, from 2012 to 2022 (forecast), covering - North America......
  • Asia-Pacific Succinylated Keyhole Limpet Hemocyanin Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 100
    In this report, the Asia-Pacific Succinylated Keyhole Limpet Hemocyanin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Succinylated Keyhole Limpet Hemocyanin for these regions, from 2012 to 2022 (forecast), including - China......
  • Asia-Pacific Sulbactam Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 110
    In this report, the Asia-Pacific Sulbactam market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Sulbactam for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan ......
  • Global Tourniquet Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 110
    In this report, the global Tourniquet market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Tourniquet in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan ......
  • 2017-2022 China Liquid Biopsy Products Market Report (Status and Outlook)
    Published: 24-May-2017        Price: US 3360 Onwards        Pages: 119
    "This report will be delivered in 2-3 business days after the order is placed." The Liquid Biopsy Products market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In China market, the top players include - RainDanceTechnologies - Biocartis - Qiagen - Guardant Health - MDxHealth - Pathway Genomics - NeoGe......
  • EMEA (Europe, Middle East and Africa) Peritoneal Dialysis Solution Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the EMEA Peritoneal Dialysis Solution market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K L), revenue (Million USD), market share and growth rate of Peritoneal Dialysis Solution for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Ital......
  • Asia-Pacific Tramadol Hcl Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 110
    In this report, the Asia-Pacific Tramadol Hcl market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Tramadol Hcl for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan......
  • Global Solid Organ Transplant Immunosuppressant Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 109
    In this report, the global Solid Organ Transplant Immunosuppressant market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Solid Organ Transplant Immunosuppressant in these regions, from 2012 to 2022 (forecast), covering - North A......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs